2007-10-19T00:00:00
The process of providing guidance and approving drugs for the NHS is flawed and needs more engagement with experts, the Commons health select committee has heard in evidence in its inquiry into the National Institute for Health and Clinical Excellence.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud